AIM has been clobbered. Are these former market darlings now unmissable bargains?

These former stars have all fallen heavily in the recent market sell-off. Time to get involved?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Last week was a pretty brutal one for most equity investors with the FTSE 100 and FTSE 250 indexes both dipping over 4% in five days.

Particularly hard hit, however, were high-growth stocks listed on the Alternative Investment Market (AIM). Mixers supplier Fevertree Drinks (LSE: FEVR), fast-fashion king ASOS (LSE: ASC), and litigation specialist Burford Capital (LSE: BUR) all endured double-digits falls, despite recovering slightly on Friday.

Warren Buffett famously preaches the strategy of being ‘greedy when others are fearful’. With confidence likely to remain fragile, is it therefore time to pick up shares in these former market darlings?

Still pricey

Go back one month and shares in Fevertree Drinks were trading as high as 4,000p each. In only a few weeks, the very same stock has tanked 27%, even after taking into account yesterday’s relatively minor rally. That’s got to be a rather bitter pill for holders to swallow, particularly those who took part in August’s placing at 3,450p a pop.

Clearly, this dramatic drop shouldn’t be regarded as a sign that Fevertree has run into trouble trading-wise. The business revealed revenue growth of 45% for the first six months of 2018, coupled with a 35% increase in adjusted EBITDA.

Trouble is, Fevertree’s valuation still looks demanding despite its recent spanking. On a forecast price-to-earnings (P/E) ratio of 57 yesterday, it’s still a screamingly expensive share to consider purchasing. 

It’s a similar story over at £4bn-cap ASOS, with the online giant trading on 40 times earnings for the 2018/19 financial year (which began at the start of September), despite being 24% cheaper to acquire than it was a week ago. Then again, its record of stellar growth means the company’s stock has rarely been on sale. 

Nor is this the first time the stock has fallen heavily. Back in 2014, its price went from just over 7,000p to a low of 1,870p in just eight months — another reminder of how backing popular growth companies can often backfire when they are priced to perfection.

While hindsight is no doubt useful here, the fact that it recovered over the years should at least give comfort to those still holding.

Of this trio of falling stars, however, Burford Capital is probably the only one whose valuation seems anywhere near attractive at the current time.

Down roughly 18% from the start of October, a P/E of 19 is a world away from the prices attached to Fevertree and ASOS. A PEG ratio of less than 1 also implies that new owners would be getting a lot of bang for their buck. The equivalent ratios for Fevertree and ASOS are 3.06 and 1.73, respectively, based on analyst forecasts. The lower this number is, the less investors are paying for growth.

A market leader in its industry, Burford continues to grow the returns it generates on the capital it invests. Debt, while rising, is still reasonable. 

Buyer beware

No one can say for sure whether Friday’s bounce was an indication that the recent rout is now over. The expectations of more interest rate rises in the US (which would heap more pressure on businesses and consumers) could mean that global equities may continue to struggle going forward.  

As always, the Foolish philosophy hasn’t changed. Buy great companies for the long term, don’t over-pay, re-invest any dividends, stay diversified, and try not to meddle. Easier said than done, of course.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended ASOS. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »